Smith Mark Douglas

Director at JAZZ; Director at PHR

Sold, on record
$1.9M
Dollars the filings state
Form 4 sales
11
Latest Jun 15, 2026
Form 144 notices
5
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • JAZZJazz Pharmaceuticals plcDirector
  • PHRPhreesia, Inc.Director

Sales by reason

1
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale JAZZNo plan
    Aug 14, 2023 2023

    Sold 1,241 shares at $138.16 ($171k)

    Smith Mark Douglas, Director

    No 10b5-1 planSold 14.5% of holdings ($1.2M position)7,305 shares left3x usual sizeFollows a Form 144Filing

  2. 2 Form 4 sale JAZZNo plan
    Dec 4, 2023 +112 days

    Sold 417 shares at $119.27 ($50k)

    Smith Mark Douglas, Director

    No 10b5-1 planSold 5.7% of holdings ($871k position)6,888 shares left0.4x usual sizeFiling

  3. 3 Form 144 notice PHRNotice
    Jul 18, 2024 +227 days

    Filed to sell 7,000 shares ($175k)

    Smith Mark Douglas, Director

    10b5-1 planFiling

  4. 4 Form 4 sale PHRRoutine
    Jul 18, 2024 same day

    Sold 7,000 shares at $25.00 ($175k)

    Smith Mark Douglas, Director

    10b5-1 planSold 18.6% of holdings ($941k position)30,653 shares leftFollows a Form 144Filing

  5. 5 Form 144 notice JAZZNotice
    Aug 5, 2024 +18 days

    Filed to sell 3,075 shares ($341k)

    Smith Mark Douglas, Director

    No 10b5-1 plan4.1x usual sizeFiling

  6. 6 Form 144 notice PHRNotice
    Jul 2, 2025 +331 days

    Filed to sell 7,000 shares ($203k)

    Smith Mark Douglas, Director

    10b5-1 planFiling

  7. 7 Form 4 sale PHRRoutine
    Jul 2, 2025 same day

    Sold 7,000 shares at $29.00 ($203k)

    Smith Mark Douglas, Director

    10b5-1 planSold 15.8% of holdings ($1.3M position)37,353 shares leftFiling

  8. 8 Form 4 sale JAZZRoutine
    Jun 15, 2026 +348 days

    Sold 1,157 shares at $230.55 ($267k)

    Smith Mark Douglas, Director

    10b5-1 planSold 10.7% of holdings ($2.5M position)9,680 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (16)

Form 144 notices and Form 4 sales by Smith Mark Douglas
Source
Jun 15, 2026Jun 17, 2026JAZZDirectorForm 4 sale1,157$267k10.7%RoutineSEC
Jul 2, 2025Jul 3, 2025PHRDirectorForm 4 sale7,000$203k15.8%RoutineSEC
Jul 2, 2025Jul 2, 2025PHRDirectorForm 144 notice7,000$203kNoticeSEC
Aug 5, 2024Aug 5, 2024JAZZDirectorForm 144 notice3,075$341kNoticeSEC
Jul 18, 2024Jul 22, 2024PHRDirectorForm 4 sale7,000$175k18.6%RoutineSEC
Jul 18, 2024Jul 18, 2024PHRDirectorForm 144 notice7,000$175kNoticeSEC
Dec 4, 2023Dec 6, 2023JAZZDirectorForm 4 sale417$50k5.7%No planSEC
Aug 14, 2023Aug 15, 2023JAZZDirectorForm 4 sale1,241$171k14.5%No planSEC
Aug 14, 2023Aug 14, 2023JAZZDirectorForm 144 notice2,561$346kNoticeSEC
Apr 3, 2023Apr 5, 2023PHRDirectorForm 4 sale7,000$215k30.3%RoutineSEC
Apr 3, 2023Apr 3, 2023PHROfficerForm 144 notice7,000$226kNoticeSEC
Dec 2, 2022Dec 6, 2022JAZZDirectorForm 4 sale420$65k7.1%Plan not statedSEC
Aug 8, 2022Aug 9, 2022JAZZDirectorForm 4 sale1,089$166k15.6%Plan not statedSEC
Dec 2, 2021Dec 6, 2021JAZZDirectorForm 4 sale417$51k8.6%Plan not statedSEC
Jan 4, 2021Jan 6, 2021PHRDirectorForm 4 sale6,000$315k49.5%UnusualSEC
Aug 10, 2020Aug 12, 2020PHRDirectorForm 4 sale6,000$182k49.5%UnusualSEC